A cikin shekaru 50 da suka gabata, fasahar ERCP ta samo asali daga kayan aiki mai sauƙi na ganewar asali zuwa wani dandamali mai sauƙin shiga ciki wanda ke haɗa ganewar asali da magani. Tare da gabatar da sabbin fasahohi kamar su endoscopy na bututun biliary da pancreas da endoscopy mai siriri, ERCP tana sauya tsarin ganewar asali da magani na gargajiya a hankali don cututtukan biliary da pancreas. Ta sami ci gaba mai mahimmanci wajen inganta daidaiton ganewar asali, faɗaɗa iyakokin alamu, da rage haɗarin rikitarwa, yana nuna yanayin ci gaban "tiyatar likita ta zama mafi yawan tiyata da tiyata ta zama mafi ƙarancin shiga ciki," yana samar da ƙarin marasa lafiya da zaɓuɓɓukan magani masu inganci da inganci. Duk da haka, tana fuskantar ƙuntatawa a aikace-aikacen asibiti, kamar manyan matakan fasaha da dogaro da kayan aiki.
Sabbin fasahohin ERCP galibi sun kasu kashi uku: tsarin endoscopic don hanyoyin bile da pancreas, endoscopes masu siriri sosai, da kuma tsarin da aka haɓaka a cikin gida. Tsarin endoscopic kamar SpyGlass da Insight-eyeMax suna ba da gani kai tsaye kuma suna taimakawa wajen yin magani mai kyau.
Daga cikinsu, tsarin SpyGlass yana da diamita na waje na catheter na 9F-11F da diamita na tashar aiki na 1.2mm ko 2.0mm, wanda ke ba da damar saka na'urar biliary da pancreas subscope na mutum ɗaya don ganin mucosa kai tsaye. Tsarin Insight-eyeMax yana da ingancin hoto mai girman pixel 160,000, filin gani na 120°, da kuma rufin da ke da santsi sosai, wanda ke ba da fili mai haske da faɗi. Endoscopes masu siriri sosai suna amfani da ƙaramin diamita na bututu (yawanci ƙasa da 5mm) don shiga bututun bile kai tsaye, amma saboda tsarin hadaddun tsarin hanji na sama, ana buƙatar kayan aiki masu taimako kamar balan-balan da ke ɗaure, cannulas na waje, da tarko sau da yawa. Waɗannan tsarin suna da fa'idodi wajen lura da mucosa na bututun bile da yin biopsy, amma suna da wahalar aiki.
 |  |
| SpyGlass | Insight-eyeMax |
Babban fa'idar sabuwar fasahar ERCP ita ce ta cimma wani babban ci gaba daga lura kai tsaye zuwa ga ganewar asali kai tsaye, wanda hakan ya ba likitoci damar lura da raunukan da ke cikin bile da pancreas mucosa cikin sauƙi da kuma yin gwaje-gwaje daidai gwargwado da kuma magani a lokaci guda yayin aikin ganewar asali. Amfaninta na asibiti galibi yana bayyana ne a fannoni uku: inganta daidaiton ganewar asali, faɗaɗa iyakokin alamun cutar, da kuma rage haɗarin rikitarwa.
Dangane da inganta daidaiton ganewar asali, cholangiopancreatography (ERCP) yana bawa likitoci damar hango mucosa na bile da pancreas kai tsaye, wanda hakan ke inganta ikon bambancewa tsakanin kunkuntar da ba ta da lahani da kuma ta hanyar cutarwa. ERCP na gargajiya ya dogara ne akan abubuwan da ke bambanta don ganin tsarin haske, kuma kimanta raunukan mucosa ya dogara ne akan alamun da ba a kaikaice ba. Jin daɗin gogewar ƙwayoyin bile shine kashi 45%-63% kawai, kuma jin daɗin biopsy na nama shine kashi 48.1% kawai.
Sabanin haka, gwajin cholangiopancreatography (CP) yana ba da damar ganin mucosa kai tsaye, wanda hakan ke inganta saurin ganewar asali sosai. Idan aka haɗa shi da MRCP, daidaiton zai iya kaiwa kashi 97.4%, kuma daidaiton ganewar asali ga duwatsun bututun bile da diamita ya wuce 9mm kusan kashi 100%. Dangane da sakamakon magani, ERCP na gargajiya yana da babban nasarar cire duwatsun bututun pancreas da diamita ƙasa da 5mm, amma babban ƙimar gazawa ga duwatsu masu rikitarwa (kamar waɗanda suka fi 2cm ko bayan sake gina gastrointestinal). CP tare da laser lithotripsy na iya inganta ƙimar nasarar zuwa kusan matakin buɗe tiyata.
Dangane da faɗaɗa iyakokin alamun, sabuwar fasahar ta inganta nasarar ERCP sosai a cikin marasa lafiya bayan tiyatar karkatar da hanji, wanda ke ba su damar sarrafa cututtukan biliary da pancreas masu rikitarwa. Misali, a cikin lokuta masu rikitarwa kamar su dashen hanta cholangitis da kuma bututun pancreas IPMN, biliary da pancreas duct endoscopy na iya samar da haske, wanda ke ba da damar ganowa da magani daidai.
Yawan kamuwa da cutar pancreatitis bayan ERCP na gargajiya kusan kashi 3%-10%. Sabbin dabaru, ta hanyar gani kai tsaye, suna rage rashin shigar da bututun pancreas, inganta hanyoyin aiki, da kuma rage lokacin aiki, wanda hakan ke rage yawan kamuwa da cutar pancreatitis bayan tiyata da sauran matsaloli. A cikin wani bincike da aka yi wa marasa lafiya 50 da ke fama da cutar cholangiocarcinoma mai yawa, lokacin da aka yi amfani da stent patency da sakamakon magani a cikin rukunin transoral cholangiopancreatography (TCP) sun yi daidai da na ƙungiyar ERCP ta gargajiya, amma ƙungiyar TCP ta nuna babban fa'ida a cikin yawan rikitarwa.
Sabuwar fasahar ERCP har yanzu tana fuskantar wasu ƙuntatawa a aikace-aikacen asibiti. Da farko, tana da babban matakin fasaha kuma tana da rikitarwa, tana buƙatar ƙwararrun likitocin endoscopist. Na biyu, ta dogara sosai da kayan aiki, tare da tsadar kulawa da aiki, wanda ke iyakance yawan amfani da ita a asibitocin kulawa na farko. Na uku, alamun sun kasance kaɗan, kuma har yanzu akwai haɗarin gazawar hanyoyin aiki a wasu yanayi. Misali, a cikin yanayin tsananin tauri na ciki (kamar tabon makogwaro) ko toshewar ƙari gaba ɗaya, canzawa zuwa PTCD ko tiyata na iya zama dole.
Sabbin fasahohin ERCP na ci gaba a nan gaba sun fi mayar da hankali kan fannoni uku: haɓakawa a matakin farko, haɗakar AI, da kuma yaɗuwar tiyatar rana. Dangane da haɓakawa a matakin farko, shirye-shiryen horarwa da fa'idodin farashi na kayan aikin da aka samar a cikin gida za su inganta ƙwarewar ERCP na asibitocin farko a hankali. Dangane da haɗakar AI, fasahar gane hoto ta ainihin lokaci tana da alƙawarin inganta ingancin bincike, amma tana fuskantar ƙalubale kamar daidaita bayanai da bayyana samfurin, wanda ke buƙatar ƙarin haɓakawa.
Dangane da yaɗuwar tiyatar yini, yarjejeniyar da aka cimma a shekarar 2025 ta inganta shigar da ERCP a cikin kula da tiyatar yini, wanda hakan ke ba wa yawancin marasa lafiya damar kammala aikin asibiti, tiyata, lura bayan tiyata, da kuma sallama cikin awanni 24. Wannan ba wai kawai yana rage zaman asibiti ba ne, har ma yana rage farashin magani da kuma inganta ingancin amfani da albarkatun likitanci. Tare da ƙarin balaga da yaɗuwar fasahar, ana sa ran za a yi amfani da ERCP a ƙarin cibiyoyin kiwon lafiya, yana samar da ingantattun ayyukan bincike da magani ga ƙarin marasa lafiya da ke fama da cututtukan biliary da pancreas.
Takaitawa da Shawarwari
ERCP, sabuwar fasaha, tana wakiltar babban ci gaba a cikin ganewar asali da maganin cututtukan biliary da pancreas. Yana inganta daidaiton ganewar asali ta hanyar gani kai tsaye da kuma biopsy daidai, yana rage haɗarin rikitarwa ta hanyar inganta hanyar da kuma rage lokacin magani, kuma yana amfanar da ƙarin marasa lafiya ta hanyar faɗaɗa kewayon alamu. Duk da haka, wannan sabuwar fasaha tana fuskantar ƙuntatawa a aikace-aikacen asibiti, kamar manyan shingen fasaha da dogaro da kayan aiki mai ƙarfi, yana buƙatar goyon bayan ƙungiyoyin likitoci na musamman da kayan aiki na zamani. Ana ba da shawarar cibiyoyin kiwon lafiya su ƙarfafa horo da saka hannun jari na ERCP don inganta ƙwarewar likitoci da wadatar kayan aiki. Hakanan ana ba da shawarar zaɓar hanyoyin magani masu dacewa bisa ga yanayin majiyyaci; don cututtukan biliary da pancreas masu rikitarwa, ana iya la'akari da maganin ERCP tare da sabbin fasahohi. Bugu da ƙari, ana ba da shawarar ƙara inganta aiki da farashin ERCP, magance matsalolin gabaɗaya da bayyana tsarin da AI ke tallafawa, da kuma haɓaka ɗaukar ERCP a asibitocin kulawa na farko.
Kayayyakin sayar da kayayyaki masu zafi na ERCP Series daga ZRHmed.
 |  |  |  |
| Sphincterotome | Jagorar da ba ta jijiyoyin jini ba | Kwandon Maido da Dutse Mai Zartarwa | Katheters na Nasobiliary da za a iya zubarwa |
Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China, wanda ya ƙware a fannin amfani da endoscopic, ya haɗa da layin GI kamar biopsy forceps, hemoclip, polyp snare, sclerotherapy allura, feshi catheter, goga cytology, guidewire, kwandon dawo da dutse, magudanar ruwa ta hanci da sauransu, waɗanda ake amfani da su sosai a EMR, ESD, ERCP. Kayayyakinmu an ba su takardar shaidar CE kuma suna da amincewar FDA 510K, kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma muna samun yabo da yabo daga abokin ciniki sosai!
Sphincterotome、Jagorar waya、Kwandon Cire Dutse、Magudanar NasobiliaryCatheter、ERCP
Lokacin Saƙo: Disamba-20-2025